SLC25A5 (ADP/ATP translocase 2, ANT2) — review notes

UniProt: P05141 (ADT2_HUMAN). Gene: SLC25A5 (HGNC:10991), X-linked (Xq24-25).
Synonyms: ANT2, AAC2, ADP/ATP carrier protein 2, "fibroblast isoform". 298 aa.

Core identity and function

SLC25A5/ANT2 is the ADP/ATP translocase (adenine nucleotide translocator, ANT)
isoform characteristically expressed in proliferative and glycolytic tissues
(fibroblasts, undifferentiated/growth-activated cells, tumors). It is a member of
the SLC25 mitochondrial carrier family (TC 2.A.29) and is an integral polytopic
protein of the mitochondrial inner membrane with the classic 6-transmembrane,
three-repeat (Solcar) carrier fold.

Primary molecular function is an ATP:ADP antiporter (GO:0005471): it exchanges
ATP synthesized in the matrix for cytosolic ADP across the inner membrane by an
alternating-access (c-state ⇄ m-state) mechanism with a single substrate-binding
site. This supplies the electron-transport chain / ATP synthase with ADP and
exports ATP to fuel the cell.

Reactome R-HSA-163215 describes the antiport reaction: "A family of antiport,
ATP-ADP translocases (SLC25A4,5,6), preferentially export ATP from the matrix
while importing ADP from the cytosol" and notes isoform 2 (SLC25A5) is the
fibroblast form [reactome:R-HSA-163215].

Note: this is a transporter, not an enzyme — do not assign a catalytic MF.

Secondary / moonlighting activities (well-supported, non-core)

  1. Proton transport / uncoupling / thermogenesis (By similarity). ANT can act
    as a fatty-acid-activated proton transporter that uncouples oxidative
    phosphorylation, contributing to thermogenesis in tissues lacking UCP1; this is
    antagonized by its ADP:ATP antiport activity, so ANT2 acts as a "master
    regulator" balancing ATP output vs thermogenesis
    [file:human/SLC25A5/SLC25A5-uniprot.txt "proton transporter: proton transport uncouples the proton flows via the"].
    All proton-transport / uncoupler / adaptive-thermogenesis annotations are ISS/IEA
    transferred from paralogs (P51881 = mouse Ant1/Slc25a4 or bovine) — plausible but
    not directly demonstrated for human ANT2; treat as KEEP_AS_NON_CORE.

  2. Mitochondrial permeability transition pore (mPTP) / apoptosis. ANT is a
    regulator (possibly component) of the mPTP. Human-specific ARHGAP11B imported
    into mitochondria "interacts with the adenine nucleotide translocase (ANT) and
    inhibits the mitochondrial permeability transition pore (mPTP)"
    PMID:31883789;
    this mPTP inhibition promotes basal-progenitor expansion/proliferation.
    UniProt: "Also plays a key role in mPTP opening ... which contributes to cell
    death (PubMed:31883789). It is however unclear if SLC25A5/ANT2 constitutes a
    pore-forming component of mPTP or regulates it"
    [file:human/SLC25A5/SLC25A5-uniprot.txt "do not express UCP1 (By similarity). Also plays a key role in mPTP"].
    Treat mPTP-complex / regulation-of-permeability / apoptosis annotations as
    KEEP_AS_NON_CORE.

  3. Mitophagy (By similarity). "Acts as a regulator of mitophagy independently of
    ADP:ATP antiporter activity: promotes mitophagy via interaction with TIMM44 ...
    promoting stabilization of PINK1"
    [file:human/SLC25A5/SLC25A5-uniprot.txt "ADP:ATP antiporter activity: promotes mitophagy via interaction with"].
    ISS/IEA from paralog; non-core.

  4. MMXD complex / chromosome segregation. ANT2 is a component of the mitotic
    spindle-associated MMXD (MMS19-MIP18-XPD) cytosolic iron-sulfur assembly complex.
    Ito et al.: "it included FAM96B (now designated MIP18), Ciao1, and ANT2"
    PMID:20797633; the
    complex "led to improper chromosome segregation" on knockdown
    PMID:20797633. This is a genuine IDA
    finding (part_of MMXD complex, GO:0071817) — a legitimate moonlighting role,
    non-core relative to the antiporter function.

Interactions (IPI "protein binding" annotations)

Most GO:0005515 "protein binding" annotations come from IntAct/proteomics
co-precipitation screens and are individually uninformative:
- SIRT4 (Q9Y6E7), PMID:17715127 (mitochondrial ADP-ribosyltransferase screen).
- SLC35F6 / C2orf18 / ANT2BP (Q8N357), PMID:19154410 — ANT2-binding protein in PDAC;
"it could interact with adenine nucleotide translocase 2 (ANT2)"
PMID:19154410.
- LRRK2 (Q5S007), PMIDs 21370995, 24725412, 35266954 — LRRK2 interactome screens.
- ADCK2 (Q7Z695), PMID:27499296 (mitochondrial interaction map).
- ARHGAP11B (Q3KRB8), PMID:31883789 — functional, mPTP-inhibiting interaction (see above).
- AK4 (P27144) / adenylate kinase, PMID:19130895 — "ANTs) interacted with AK4"
PMID:19130895; the paper also
co-precipitates prohibitin (P21796). Physiologically plausible (AK4 in matrix,
ANT in inner membrane, both in adenine-nucleotide handling).
- PHB2 (Q99623), PMID:19116139 — capsaicin/prohibitin-2 study; ANT2 pulled down.
- Parkin/PRKN (O60260), PMID:19725078 — "ubiquitin protein ligase binding"
(GO:0031625); SLC25A5 co-purified as a Parkin interactant. "potential interactants
of Parkin; ... SLC25A5" PMID:19725078.

Per policy, bare "protein binding" IPI is not removed; mark as
MARK_AS_OVER_ANNOTATED (uninformative MF) or, for informative specific ones
(ubiquitin ligase binding), ACCEPT/KEEP_AS_NON_CORE.

Localization annotations

Suspect / over-annotated MF calls

Process annotations

Summary of core functions

  1. ATP:ADP antiporter activity (GO:0005471) in the mitochondrial inner membrane
    (GO:0005743), driving mitochondrial ADP/ATP transmembrane transport (GO:0140021,
    GO:1990544) in support of oxidative phosphorylation.

Everything else (proton/uncoupling, mPTP/apoptosis, mitophagy, MMXD/chromosome
segregation, proliferation, differentiation programs, individual interactions) is
secondary or context-specific and reviewed as non-core.